ProRx LLC

Form 483 issued August 2, 2024 · Exton, Pennsylvania

Inspection
Jul 15 – Aug 2, 2024
Observations
13
Pages
14
FEI number
3022250654

In short: On August 2, 2024, FDA issued a Form 483 with 13 observations to ProRx LLC in Exton, Pennsylvania (FEI 3022250654) after an inspection that ran Jul 15 – Aug 2, 2024. The investigators were Jazmine N. Brown and Karishma G. Gopaul. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment4
Production3
Quality system2
Laboratory controls1
Other3

Most cited: 21 CFR 211.113(b) (2×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    The responsibilities and procedures applicable to the quality…

9 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at ProRx LLC?

FDA listed 13 observations on this Form 483, mostly about facilities & equipment, production and quality system. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected ProRx LLC?

Jazmine N. Brown and Karishma G. Gopaul are named on this Form 483, for the inspection of Jul 15 – Aug 2, 2024. Each investigator has a profile showing what they cite most.

When was ProRx LLC inspected by FDA?

The inspection ran Jul 15 – Aug 2, 2024, and the Form 483 is dated August 2, 2024.

How do I get the full Form 483 for ProRx LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free